Sunday, May 15, 2016 9:00 a.m. - 4:15 p.m. |
A31 |
Asthma Therapy: Glucocorticoids and Beyond |
A32 |
Adaptive Immunity in Lung Disease |
A33 |
Airway Smooth Muscle |
A34 |
ARDs and Lung Injury |
A35 |
Case Reports in Autoimmune Lung Disease |
A36 |
Clinical Problems in Asthma and Allergy |
A37 |
Cystic Fibrosis: Immune Regulatory Pathways |
A38 |
Diagnostic Markers of Asthma and COPD |
A39 |
Eosinophilic Airways Disease |
A40 |
Epithelial Regulation of Inflammation |
A41 |
The Spectrum COPD Care: From Identification to Policy |
A42 |
Autoimmune Myositis, Antisynthetase, Scleroderma, and IPAF |
A43 |
Alpha-1-Antitrypsin |
A44 |
Drug Induced and Rare Lung Disease |
A45 |
Lung Disease Associad with Biological Therapy and Immunotherapy: Case Reports |
A46 |
Lung Disease Due to OTC and Illicits: Case Reports |
A47 |
Rare Interstitial Lung Disease: Case Reports |
A48 |
Conventional Drug Associated Lung Disease |
A49 |
COPD: Care Delivery |
A50 |
Asthma: Observatonal Studies |
A51 |
Bronchiectasis: Clinical and Epidemiologic Studies |
A52 |
Critical Care: ICU Procedures, Processes of Care, and Novel Techniques |
A53 |
Respiratory Failure: Risk Factors and Outcomes in ARDS |
A54 |
Critical Care Case Reports: Acute Hypoxemic Respiratory Failure/ARDS |
A55 |
Critical Care Case Reports: Neuro Critical Care and Toxicology |
A56 |
Criical Care Case Reports: Hematology/Oncology |
A57 |
Critical Care Case Reports: Non-Pulmonary Critical Care |
A58 |
Epidemiology of COPD and Lung Cancer |
A59 |
Tobacco, Nicotine, and Marijuana Use |
A60 |
ILD, IPF, Sarcoidosis, and Diffuse Lung Disease |
A61 |
Clinical Aspets of Non-Bacterial Lung Infections |
A62 |
Clinical Aspecs of CAP, HCAP, HAP and VAP |
A63 |
Pediatric Asthma: Predictors and Outcomes |
A64 |
Translational Research in Pediatric Asthma |
A65 |
NICU, PICU and Chronic Ventilation |
A66 |
PH: Molecules,Cells and Animal Models |
A67 |
Case Repors in Pulmonay Vascular Disease |
A68 |
The Rising: Understanding the Right Ventricle |
A69 |
Pulmonary Rehabilitation in Pulmonay Hypertension, Interstitial Lung Disease, and Other Conditions: What's New? |
A70 |
The Good, the Bad and the Ugly of Aging |
A71 |
Epigenetics |
A72 |
Mechanisms of Lung Cancer Biology |
A73 |
Lung Fibrosis: New Directions to Inform the Future |
A74 |
Matrix: Drivers and Targets |
A75 |
Stem Cells |
A76 |
LAM: New Biology and New Insights |
A77 |
Airway Smooth Muscle: Tuning, Tinkering, and Treating |
A78 |
Airway Smooth Muscle: What's Under the Hood? |
A79 |
Lung Imaging: CT and Beyond |
A80-A |
Are HSTS Obsolete? Novel Diagnostics in SDB |
A80-B |
Viewing OSA Pathogenesis in Color Insead of Black and White |
A80-C |
Molecular and Immunobiology of Lung Cancer |
Monday, May 16, 2016 9:00 a.m. - 4:15 p.m. |
B31 |
Alpha-1 Antitrypsin |
B32 |
Alveolar Macrophage Biology-C |
B33 |
Antioxidants, Vitamins and Related Pathways in Airways Disease |
B34 |
Case Report in Immunodeficiences and Allergy |
B35 |
Innovations in Medical Education |
B36 |
Pleural Disease: Clinical Studies |
B37 |
Interventional Pulmonary Medicine: Cool Cases |
B38 |
Pleural Disease: Clinical Studies |
B39 |
Interventional Pulmonary Medicine: Recent Advances |
B40 |
Dyspnea: Case Reports |
B41 |
Lung Transplantation: Clinical and Translational Studies |
B42 |
COPD: Biomarkers |
B43 |
COPD: Phenotypes and Clinical Outcomes |
B44 |
COPD: Comorbidities |
B45 |
Obstructive Lung Disease: Interesting Cases |
B46 |
Critical Care: ICU Epidemiology and Outcomes |
B47 |
Critical Care: Clinical Research Discoveries, Epidemiology, and Health Services for Sepsis |
B48 |
Asthma: Insights from the Bench, Genetics and Epidemiology |
B49 |
Non-Tuberculous Mycobacterial Disease and Case Reports |
B50 |
Tuberculosis: Case Reports |
B51 |
Pediatric Asthma: Evaluation and Treatment |
B52 |
Neonatal Lung Disease: From Bench to Babies |
B53 |
Phound in Translation |
B54 |
Case Reports in Pulmonary Circulation |
B55 |
Reason to Believe: Clinical PH Studies |
B56 |
The Art and Science of Rehabilitation: Novel Treatments and Outcomes in Pulmonary Rehabilitation |
B57 |
Fibrosis Biology |
B58 |
Big and Bigger (Data): Omics and Biomarkers of COPD and Other Chronic Lung Diseases |
B59 |
Novel Genes and Gene Effects in COPD |
B60 |
Smoking and Particulates Impact on Lung Health |
B61 |
Fibroblasts and Matrix in COPD |
B62 |
The Biology of Scarring: Where are they Now? |
B63 |
My Way: OSA Outpatient Models of Care |
B64 |
Bop Goes the Heart: Cardiovascular Consequences of SDB |
B65 |
Things that Go Bump in the Night: Sleep Case Studies and Non-OSA Sleep |
B66 |
Lung Cancer Screening and Nodule Evaluation |
B67 |
Thoracic Oncology: General Aspects |
Tuesday, May 17, 2016 9:00 a.m. - 4:15 p.m. |
C31 |
Experimental Asthma Therapies |
C32 |
Imaging Inflammation in the Lung |
C33 |
Immune Pathology of Viral Infections |
C34 |
Immune Regulation of Transplant Rejection |
C35 |
Innate Immune Mechanisms in COPD |
C36 |
Novel Mechanisms of Allergic Airway Inflammation in Animal Models |
C37 |
Pulmonary Fibrosis |
C38 |
New Developments in Asthma Care, Methods and Outcomes |
C39 |
IPF: More on Diagnosis and Therapy |
C40 |
Sarcoidosis: Understanding this Multi-System Disorder |
C41 |
Sarcoidosis: Case Reports |
C42 |
LAM, Cystic Lung Disease, and Mimics: Case Reports |
C43 |
Pulmonary Alveolar Proteinosis and Other Rare Lung Disease: Case Reports |
C44 |
Diffuse Parenchymal Lung Disease: Case Reports |
C45 |
Dyspnea: Takes your Breath Away |
C46 |
Cough: Evaluaton and Treatment |
C47 |
COPD: Exacerbations |
C48 |
COPD: Imaging |
C49 |
Respiratory Failure: Clinical and Translational Aspects of Vili and Lung Protective MV |
C50 |
Critical Care: Delirium and Sedation in the ICU |
C51 |
Respiratory Failure: High Flow Oxygen, Liberation, Non-Invasive, and Prolonged Ventilation |
C52 |
Critical Care Case Reports: Respiratory Failure/Mechanical Ventilation |
C53 |
Critical Care Case Reports: Multisystem Organ Failure |
C54 |
Critical Care Case Reports: Sepsis |
C55 |
Cardiopulmonary Effects of Air Pollution |
C56 |
Occupational Medicine and Lung Function |
C57 |
Cellular/Molecular Mechanisms and Translational Aspects of Respiratory Infections |
C58 |
Tuberculosis Infection and Disease |
C59 |
Topics on Self-Management and Supportive Care Scross the Spectrum of Chronic Respiratory Conditions |
C60 |
All About Cystic Fibrosis |
C61 |
Pediatric Sleep: Screening and Outcomes |
C62 |
Pediatric Cases I |
C63 |
Born to Run: Exercise in Cardiopulmonary Disease |
C64 |
ALI and Barrier Function |
C65 |
One Step Up from PE to CTEPH |
C66 |
"Walk this Way" - Update on Exercise Tests and Pulmonary Rehabilitation |
C67 |
Acute Lung Injury |
C68 |
Immune Cell Interactions in COPD |
C69 |
Here's Looking at You: Imaging Studies in COPD |
C70 |
The Next New Therapeutic Target? Translational Studies of COPD Therapies |
C71 |
You Are What You Breathe: Airway Cell Biology in COPD |
C72 |
Epthelial Biology |
C73 |
Oxidants |
C74 |
Models and Methods in Lung Biology |
C75 |
Improving and Assessing Respiratory Function |
C76 |
Ventilatory Control: Getting on my Nerves |
C77 |
Digging Down Deep: Measuring SDB Physiological Traits |
C78 |
Not Strangers in the Night: Sleep and Thoracic Diseases |
C79 |
Multimodality Approaches to Diagnosis and Treatment of Lung Cancer |
C80 |
Thoracic Oncology: Case Reports |
C81 |
Unusual Presentations of Lung Cancer: Case Reports |
Wednesday, May 18, 2016 9:00 a.m. - 4:15 p.m. |
D31 |
Novel Mechanisms of Allergy and Airway Inflammation |
D32 |
Pneumonia |
D33 |
Role of Oxidative Stress in Inflammation |
D34 |
Sarcoidosis |
D35 |
Sepsis: Innate Immune Mechanisms |
D36 |
COPD: LABA, LAMA, ICS, and Combinations |
D37 |
COPD: Developmental Therapeutics |
D38 |
COPD: Physiologic Evaluation |
D39 |
COPD: Non-Pharmacologic Therapies |
D40 |
Critical Care: Diagnosing and Treating Bacterial and Viral Infections in the ICU |
D41 |
Critical care Case Reports: Cardiovascular Disease and Hemodynamics I |
D42 |
Critical Care Case Reports: Cardiovascular Disease and Hemodynamics II |
D43 |
Critical Care Case Reports: Infections Leading to Critical Illness |
D44 |
Respiratory Failure: Extracorporeal Life Support |
D45 |
Critical Care: Circulatory Hemodynamics, Shock, Cardiovascular Disease, and Fluid Management |
D46 |
Case Reports in Environmental and Occupational Health |
D47 |
Epidemiologic Aspects of Tuberculosis and Bacterial Infections |
D48 |
Lung Infection Case Reports I: Fungal Infections |
D49 |
Lung Infection Case Reports II: Infections Other than Fungal Infections |
D50 |
Pediatric Rare Lung Diseases |
D51 |
Pediatric Cases II |
D52 |
Molecular Insight into Pulmonary Hypertension |
D53 |
The Promised Land: Clinical Studies in Pulmonary Hypertension |
D54 |
Clinical Pulmonary Hypertension |
D55 |
Lab Methodology and Bioengineering: Just Do It |
D56 |
Cuddle up a Little Closer: SDB Nonpulmonary Overlaps |
D57 |
Don't be a Do-Badder: New Interventions for OSA |